Cuprina (CUPR) Stock Analysis

What Cuprina does

Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.

Key metrics

ETFs linked to CUPR

Broad-market and Healthcare sector ETFs an investor holding Cuprina is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CUPR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Cuprina?

Cuprina trades under the ticker CUPR on NASDAQ.

Which exchange is CUPR listed on?

CUPR is listed on NASDAQ.

What sector does Cuprina operate in?

Cuprina is classified in the Healthcare sector (Medical - Instruments & Supplies industry).

How can PortView help analyze CUPR in a portfolio?

PortView shows CUPR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.